PAF/cytokine auto-generated feedback networks in microvascular immune injury: consequences in shock, ischemia and graft rejection.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Journal of lipid mediators

• Publication date

  1989-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 2519889
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Histological changes of bile duct in experimental graft-versus-host disease across minor histocompatibility barriers. II. Electron microscopic observations.

  2008cited by this paper
• Human skin proteases

  2004cited by this paper
• Is there a case for PAF antagonists in the treatment of ischemic states?

  1989cited by this paper
• Endothelial activation during interleukin 2 immunotherapy. A possible mechanism for the vascular leak syndrome.

  1988cited by this paper
• The effect of the selective PAF antagonist BN 52021 on PAF- and antigen-induced bronchial hyper-reactivity and eosinophil accumulation.

  1988cited by this paper
• Human granulocyte-macrophage colony-stimulating factor and other cytokines prime human neutrophils for enhanced arachidonic acid release and leukotriene B4 synthesis.

  1988cited by this paper
• Studies on the adhesive interaction between purified human eosinophils and cultured vascular endothelial cells.

  1988cited by this paper
• Role of Na+/H+ exchange in thrombin-induced platelet-activating factor production by human endothelial cells.

  1988cited by this paper
• Effect of tumor necrosis factor on GTP binding and GTPase activity in HL-60 and L929 cells.

  1988cited by this paper
• Endogenous platelet-activating factor and anti-platelet-activating factor in patients with renovascular hypertension.

  1988cited by this paper
• Platelet-activating factor primes neutrophil responses to agonists: role in promoting neutrophil-mediated endothelial damage.

  1988cited by this paper
• The priming of neutrophils by lipopolysaccharide for production of intracellular platelet-activating factor. Potential role in mediation of enhanced superoxide secretion.

  1988cited by this paper
• Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion.

  1988cited by this paper
• The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells

  1988cited by this paper
• Recombinant human tumor necrosis factor‐α: Thrombus formation is a cause of anti‐tumor activity

  1988cited by this paper
• Granulocyte-macrophage colony-stimulating factor modulates the excitation-response coupling sequence in human neutrophils.

  1988cited by this paper
• Multiple actions of interleukin 6 within a cytokine network.

  1988cited by this paper
• Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion, and selective antagonists.

  1988cited by this paper
• B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes.

  1988cited by this paper
• Synthesis and release of platelet-activating factor is inhibited by plasma alpha 1-proteinase inhibitor or alpha 1-antichymotrypsin and is stimulated by proteinases

  1988cited by this paper
• Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1 alpha.

  1988cited by this paper
• Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors

  1988cited by this paper
• Synergism among interleukin 1, interleukin 3, and interleukin 5 in the production of eosinophils from primitive hemopoietic stem cells.

  1988cited by this paper
• IL-1 induces IL-1. III. Specific inhibition of IL-1 production by IFN-gamma.

  1988cited by this paper
• Endothelium from Diverse Vascular Sources Synthesizes Platelet‐Activating Factor

  1988cited by this paper
• The role of cachectin/TNF in endotoxic shock and cachexia.

  1988cited by this paper
• B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes

  1988cited by this paper
• Colony-stimulating factor 1-induced Na+ influx into human monocytes involves activation of a pertussis toxin-sensitive GTP-binding protein.

  1988cited by this paper
• Platelet activating factor and leukotriene B4 induce hyperpolarization of human endothelial cells but depolarization of neutrophils.

  1988cited by this paper
• Serum inhibitors of interleukin-2.

  1988cited by this paper
• Leukotriene production in human neutrophils primed by recombinant human granulocyte/macrophage colony-stimulating factor and stimulated with the complement component C5A and FMLP as second signals

  1988cited by this paper
• Adherence of human basophils to cultured umbilical vein endothelial cells.

  1988cited by this paper
• Stimulation of eosinophil adherence to human vascular endothelial cells in vitro by platelet-activating factor.

  1988cited by this paper
• Elevated levels of the 26K human hybridoma growth factor (interleukin 6) in cerebrospinal fluid of patients with acute infection of the central nervous system.

  1988cited by this paper
• Human granulocyte-monocyte colony-stimulating factor and interleukin 3 stimulate monocyte cytotoxicity through a tumor necrosis factor-dependent mechanism.

  1988cited by this paper
• IL-1-induced adhesion of polymorphonuclear leukocytes to cultured human endothelial cells. Role of platelet-activating factor.

  1988cited by this paper
• Effect of platelet-activating factor on leukocyte adhesion to microvascular endothelium

  1988cited by this paper
• Stimulation of guanylate cyclase activity and reduction of adenylate cyclase activity by granulocyte-macrophage colony-stimulating factor in human blood neutrophils.

  1988cited by this paper
• Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor.

  1988cited by this paper
• A urine inhibitor of interleukin 1 activity affects both interleukin 1 alpha and 1 beta but not tumor necrosis factor alpha.

  1987cited by this paper
• Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor

  1987cited by this paper
• Synergistic and antagonistic effects of recombinant human interleukin (IL) 3, IL-1 alpha, granulocyte and macrophage colony-stimulating factors (G-CSF and M-CSF) on the growth of GM-CSF-dependent leukemic cell lines.

  1987cited by this paper
• Porcine coronary arteries with regenerated endothelium have a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin.

  1987cited by this paper
• Human GM-CSF primes neutrophils for enhanced oxidative metabolism in response to the major physiological chemoattractants.

  1987cited by this paper
• Occurrence of an endogenous inhibitor of platelet-activating factor in rat liver.

  1987cited by this paper
• Effect of platelet-activating factor (PAF-acether) and its specific receptor antagonist, BN 52021, on interleukin 1 (IL1) release and synthesis by rat spleen adherent monocytes.

  1987cited by this paper
• Platelet‐Activating Factor Effects on Bovine Pulmonary Artery Endothelial Cells

  1987cited by this paper
• Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor

  1987cited by this paper
• Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.

  1987cited by this paper
• Alpha-melanocyte-stimulating hormone exhibits target cell selectivity in its capacity to affect interleukin 1-inducible responses in vivo and in vitro.

  1987cited by this paper
• B-cell-stimulatory factor 2 (beta 2 interferon) functions as a second signal for interleukin 2 production by mature murine T cells.

  1987cited by this paper
• Platelet-activating factor (PAF) stimulates the PAF-synthesizing enzyme acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine O2-acetyltransferase and PAF synthesis in neutrophils.

  1987cited by this paper
• Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor.

  1987cited by this paper
• Inhibition of human lymphocyte proliferation and interleukin 2 production by platelet activating factor (PAF-acether): reversal by a specific antagonist, BN 52021.

  1987cited by this paper
• Interferon-gamma is produced by activated immature mouse thymocytes and inhibits the interleukin 4-induced proliferation of immature thymocytes.

  1987cited by this paper
• Modulation of endothelial cell functions by different molecular species of interleukin 1.

  1987cited by this paper
• B-cell stimulatory factors (BSFs): Molecular structure, biological function, and regulation of expression

  1987cited by this paper
• PAF-acether today--relevance for acute experimental anaphylaxis.

  1987cited by this paper
• Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentiation factor (interleukin 5).

  1987cited by this paper
• Regulation of acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine O2-acetyltransferase (lyso-PAF-acetyltransferase) in exocrine glands. Evidence for an activation via phosphorylation by calcium/calmodulin-dependent protein kinase.

  1987cited by this paper
• Interleukin 4 (B-cell stimulatory factor 1) can enhance or antagonize the factor-dependent growth of hemopoietic progenitor cells.

  1987cited by this paper
• Intravascular release of platelet activating factor in children with sepsis.

  1987cited by this paper
• Serum levels of interleukin-6 and acute phase responses.

  1987cited by this paper
• Perspectives in platelet-activating factor research.

  1987cited by this paper
• Inhibition of rat endotoxin-induced lethality by BN 52021 and BN 52063, compounds with PAF-acether antagonistic effect and protease-inhibitory activity.

  1987cited by this paper
• Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species.

  1987cited by this paper
• Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome.

  1987cited by this paper
• Interleukin 1 inhibitor masks high interleukin 1 production in acquired immunodeficiency syndrome (AIDS).

  1987cited by this paper
• Human endothelial cells are target for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeleton structures.

  1987cited by this paper
• Effects of recombinant human granulocyte and macrophage colony-stimulating factors on signal transduction pathways in human granulocytes.

  1987cited by this paper
• Studies on the mechanism of interleukin 1 stimulation of platelet activating factor synthesis in human endothelial cells in culture.

  1987cited by this paper
• Platelet-activating factor and cellular immune responses.

  1987cited by this paper
• Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor.

  1986cited by this paper
• Shock and tissue injury induced by recombinant human cachectin.

  1986cited by this paper
• Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils.

  1986cited by this paper
• Correlation of macrophage‐mediated tumor‐cell lysis with the production of macrophage cytolytic factor (CF). preliminary characterization of a factor inhibiting cf production

  1986cited by this paper
• Interleukin 1 stimulates platelet-activating factor production in cultured human endothelial cells.

  1986cited by this paper
• Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival.

  1986cited by this paper
• Granulocyte-macrophage colony-stimulating factor enhances phagocytosis of bacteria by human neutrophils.

  1986cited by this paper
• Involvement of K+ movements in the membrane signal induced by PAF-acether.

  1986cited by this paper
• Human recombinant granulocyte-macrophage colony-stimulating factor increases cell-to-cell adhesion and surface expression of adhesion-promoting surface glycoproteins on mature granulocytes.

  1986cited by this paper
• Induction of beta 2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation.

  1986cited by this paper
• Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2.

  1986cited by this paper
• Alpha melanocyte stimulating hormone inhibits immunostimulatory and inflammatory actions of interleukin 1.

  1986cited by this paper
• Release of lymphokines after infection with Epstein Barr virus in vitro. II. A monocyte-dependent inhibitor of interleukin 1 downregulates the production of interleukin 2 and interferon-gamma in rheumatoid arthritis.

  1986cited by this paper
• Catecholamine-induced suppression of interleukin-1 production.

  1986cited by this paper
• Expression of interleukin 2, interferon-gamma, and the IL 2 receptor by human peripheral blood lymphocytes.

  1986cited by this paper
• Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells.

  1986cited by this paper
• Alkyl-ether phosphoglycerides influence calcium fluxes into human endothelial cells.

  1985cited by this paper
• Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines.

  1985cited by this paper
• Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro.

  1985cited by this paper
• The effect of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (paf-acether) on the arterial wall.

  1985cited by this paper
• Modulation of lyso-platelet activating factor: acetyl-CoA acetyltransferase from rat splenic microsomes. The role of cyclic AMP-dependent protein kinase.

  1985cited by this paper
• Ultrastructural evidence for extravascular platelet recruitment in the lung upon intravenous injection of platelet-activating factor (PAF-acether) to guinea-pigs.

  1985cited by this paper
• Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta.

  1985cited by this paper
• Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate.

  1985cited by this paper
• Synthesis of PAF-acether and blood volume changes in gram-negative sepsis.

  1985cited by this paper
• Effect of platelet activating factor on endothelial permeability to plasma macromolecules.

  1984cited by this paper
• Hyperacute renal allograft rejection in the rabbit. The role of platelet-activating factor and of cationic proteins derived from polymorphonuclear leukocytes and from platelets.

  1984cited by this paper
• Role of cell surface contact in the kinetics of superoxide production by granulocytes.

  1983cited by this paper

• Inflammation in Metabolic and Cardiovascular Disorders—Role of Oxidative Stress

  2021cites this paper
• Effect of Platelet-Activating Factor on Barrier Function of ARPE-19 Cells

  2020cites this paper
• Effect of Platelet-Activating Factor on Barrier Function of ARPE-19 Cells

  2020cites this paper
• Ginkgolide B protects human pulmonary alveolar epithelial A549 cells from lipopolysaccharide‐induced inflammatory responses by reducing TRIM37‐mediated NF‐κB activation

  2020cites this paper
• Effect of Platelet-Activating Factor on Barrier Function of ARPE-19 Cells

  2018cites this paper
• Flaxseed and endotoxic shock.

  2014cites this paper
• A Novel Platelet-Activating Factor Receptor Antagonist Inhibits Choroidal Neovascularization and Subretinal Fibrosis

  2013cites this paper
• Complement Activation and Cardiac Surgery: A Novel Target for Improving Outcomes

  2012cites this paper
• Mechanisms of Platelet-Activating Factor-induced Enhancement of VEGF Expression

  2011cites this paper
• Platelet‐activating factor‐induced NF‐&kgr;B activation and IL‐8 production in intestinal epithelial cells are Bcl10‐dependent

  2010cites this paper
• Instilação nasal de LPS ou suco gástrico como fator exacerbador da inflamação pulmonar ocasionada pela isquemia e reperfusão intestinal em camundongos.

  2009cites this paper
• Synthesis of platelet-activating factor and its receptor expression in Kupffer cells in rat carbon tetrachloride-induced cirrhosis.

  2008cites this paper
• Platelet activating factor production and proinflammatory gene expression in endotoxin-challenged bovine mammary endothelial cells.

  2008cites this paper
• EFFECT OF SELECTED NATURAL PRODUCTS, THIOPROLINE AND PEGASYS ® ON HEPATIC PLATELET ACTIVATING FACTOR (PAF) IN CCL4-INDUCED HEPATIC FIBROSIS IN RATS

  2007cites this paper
• Excitable membranes, lipid messengers, and immediate-early genes

  2007cites this paper
• UNIVERSIDADE DO ESTADO DO RIO DE JANEIRO CENTRO BIOMÉDICO FACULDADE DE CIÊNCIAS MÉDICAS PÓS-GRADUAÇÃO EM FISIOPATOLOGIA CLÍNICA E EXPERIMENTAL ESTUDO DA MICROCIRCULAÇÃO E DO EFEITO DO ÓLEO DE PEIXE E DE SEUS COMPONENTES PURIFICADOS EM RETALHOS CUTÂNEOS RANDOMIZADOS EM HAMSTERS

  2007cites this paper
• Platelet-activating factor-induced NF-j B activation enhances VEGF expression through a decrease in p 53 activity

  2006cites this paper
• Platelet‐activating factor‐induced NF‐κB activation enhances VEGF expression through a decrease in p53 activity

  2006cites this paper
• New trends in PAF antagonist research: A new series of potent hetrapazine-derived PAF antagonists

  2005cites this paper
• Increased hepatic platelet activating factor (PAF) and PAF receptors in carbon tetrachloride induced liver cirrhosis

  2004cites this paper
• Kupffer cells are a major source of increased platelet activating factor in the CCl4-induced cirrhotic rat liver.

  2003cites this paper
• Prediktivna vrijednost promjena u hemostaznom sistemu kod bolesnika sa ishemijskom bolešću mozga

  2002cites this paper
• Platelet-activating factor (PAF) enhances apoptosis induced by ultraviolet radiation in corneal epithelial cells through cytochrome c-caspase activation

  2001cites this paper
• Platelet-Activating Factor

  2000cites this paper
• Antagonist ) in Patients with Severe Sepsis ( Platelet-Activating Factor Receptor an Infusion of Lexipafant A Double-Blind Placebo-Controlled Study of

  2000cites this paper
• A Double-Blind Placebo-Controlled Study of an Infusion of Lexipafant (Platelet-Activating Factor Receptor Antagonist) in Patients with Severe Sepsis

  2000cites this paper
• Effects of single intraperitoneal injections of an extract of Ginkgo biloba (EGb 761) and its terpene trilactone constituents on barbital-induced narcosis in the mouse.

  1999cites this paper
• Platelet-Activating Factor and Platelet-Activating Factor Antagonists in Acute Pancreatitis

  1999cites this paper
• Gastric cytoprotection is secondary to increased mucosal fluid secretion: a study of six cytoprotective agents in the rat.

  1998cites this paper
• The bioregulatory role of platelet-activating factor in intracellular processes and cell-cell interactions.

  1998cites this paper
• Oxygen Free Radicals and Endotoxic Shock: Effect of Flaxseed

  1998influential citation
• Confirmatory platelet-activating factor receptor antagonist trial in patients with severe gram-negative bacterial sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. BN 52021 Sepsis Investigator Group.

  1998cites this paper
• Esculentoside A Inhibits Tumor Necrosis Factor, Interleukin-1, and Interleukin-6 Production Induced by Lipopolysaccharide in Mice

  1998cites this paper
• The Role of Platelet‐Activating Factor in Musculocutaneous Flap Reperfusion Injury

  1997cites this paper
• Acute portal hypertension reflecting shear stress as a trigger of liver regeneration following partial hepatectomy

  1997cites this paper
• Dietary flax seed in prevention of hypercholesterolemic atherosclerosis.

  1997cites this paper
• Pathological Aspects of Platelet-Activating Factor (PAF)

  1997cites this paper
• Platelet-Activating Factor and Its Antagonists: Scientific Background and Clinical Applications of Ginkgolides

  1997cites this paper
• Prospective placebo‐controlled randomized trial of lexipafant in predicted severe acute pancreatitis

  1997cites this paper
• NO in Septic Shock

  1997cites this paper
• The effect of combination therapy with EPC-K1 and low-dose cyclosporine to pulmonary allograft after rat lung transplantation.

  1997cites this paper
• Nitric Oxide and the Kidney

  1997cites this paper
• Inhibitory effect of esculentoside A on tumour necrosis factor α production by human monocytes

  1996cites this paper
• The Role of Nitric Oxide in the Modulation of the Leukocyte-Endothelial Cell Interactions during Ischemia and Reperfusion

  1996cites this paper
• Recombinant tumour necrosis factor-alpha and platelet-activating factor synergistically increase intercellular adhesion molecule-1 and E-selectin-dependent neutrophil adherence to endothelium in vitro.

  1996cites this paper
• Potential Strategies for Inflammatory Mediator Manipulation: Retrospect and Prospect

  1996cites this paper
• The use of lexipafant in the treatment of acute pancreatitis.

  1996cites this paper
• The role of the microcirculation in multiple organ dysfunction syndrome (MODS): a review and perspective

  1996cites this paper
• Platelet-activating factor and the cytokine network in inflammatory processes

  1995cites this paper
• Effect of a novel potent platelet-activating factor antagonist, modipafant, in clinical asthma.

  1995cites this paper
• Inhibition of Induction or Activity of Nitric Oxide Synthase: Novel Approaches for the Therapy of Circulatory Shock

  1995cites this paper
• Investigational Therapy of Sepsis: Anti-TNF, IL-1ra, Anti-PAF and G-CSF

  1995cites this paper
• Distinct biochemical responses of hepatic macrophages and endothelial cells to platelet‐activating factor during endotoxemia

  1995cites this paper
• Effects of triazolodiazepine on the production of interleukin-6 from murine spleen cells and rabbit synovial cells in vitro

  1995cites this paper
• PAF-antagonist administration after hemorrhage-resuscitation prevents splenocyte immunodepression.

  1995cites this paper
• Platelet activating factor antagonists.

  1995cites this paper
• Effect of platelet activating factor antagonists in different models of thrombosis.

  1994cites this paper
• Platelet-activating factor (PAF): implications for coronary heart and vascular diseases.

  1994cites this paper
• Changes and Relationship of PAF and TNF in Rats with Myocardial Ischaemia and Reperfusion Injury

  1994cites this paper
• PAF-cytokine autocatalytic feed-back network in septic shock: involvement in acute renal failure.

  1994cites this paper
• Platelet-Activating-Factor-Induced Changes in Cardiovascular Function and Oxyradical Status of Myocardium in Presence of the PAF Antagonist CV-6209

  1994cites this paper
• Cytokine Production by Human Colonic Intraepithelial Lymphocytes in Controls and Ulcerative Colitis

  1994cites this paper
• Effect of superoxide dismutase on hemorrhagic hypotension and retransfusion-evoked middle cerebral artery endothelial dysfunction.

  1994cites this paper
• Platelet-activating factor antagonists: scientific background and possible clinical applications.

  1994cites this paper
• Adenosine Nucleotides and Serotonin Stimulate von Wille-brand Factor Release from Cultured Human Endothelial Cells

  1994cites this paper
• Hyperacute rejection in an ex vivo model of renal xenografting. Role of the mediator response and its pharmacologic manipulation by the specific platelet-activating factor antagonist WEB 2086BS.

  1994cites this paper
• Lipopolysaccharide-induced pleural neutrophil accumulation depends on marrow neutrophils and platelet-activating factor.

  1994cites this paper
• [Microcirculation and rheology].

  1994cites this paper
• Hemodynamic changes during acute rejection of small bowel allografts.

  1994cites this paper
• Clinical experience with platelet-activating factor antagonists. Past, present, and near future.

  1994cites this paper
• The role of the L-arginine: nitric oxide pathway in circulatory shock.

  1994cites this paper
• Platelet‐activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: A randomized, double‐blind, placebo‐controlled, multicenter clinical trial

  1994cites this paper
• Platelet-Activating Factor: Pathophysiological Changes and Therapeutic Implications in Sepsis

  1994cites this paper
• 8 – Biological Properties of Platelet-Activating Factor

  1994cites this paper
• Platelet-Activating Factor and Calcium Signaling: Its Implication in Cellular Responses

  1994cites this paper
• Platelet‐activating factor secreted by DDAVP‐treated monocytes mediates von willebrand factor release from endothelial cells

  1993cites this paper
• Molecular Mechanisms of Cellular Responses to DDAVP

  1993cites this paper
• PAF-induced amplification of mediator release in septic shock: prevention or downregulation by PAF antagonists.

  1993cites this paper
• Platelet-activating factor antagonists (BN 52021 and BN 50730) inhibit tumor necrosis factor-alfa-mediated cytotoxicity on murine L929 tumor cells.

  1993cites this paper
• Platelet-activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide.

  1993cites this paper
• Bacteria induce release of platelet-activating factor (PAF) from polymorphonuclear neutrophil granulocytes: possible role for PAF in pathogenesis of experimentally induced bacterial pneumonia

  1993cites this paper
• Restricted replication of respiratory syncytial virus in human alveolar macrophages.

  1993cites this paper
• Tulopafant, a PAF receptor antagonist, increases capillary patency and prolongs survival in discordant cardiac xenotransplants.

  1993cites this paper
• Differential sensitivity of mouse strains to platelet activating factor-induced vasopermeability and mortality: effect of antagonists.

  1993cites this paper
• Ischemia reperfusion injury: A review

  1993cites this paper
• Mechanism of the contractile response to platelet-activating factor (PAF) of the rat stomach fundus. I. PAF-induced contractile response and calcium mobilization.

  1993cites this paper
• Platelet-Activating Factor in Shock, Sepsis, and Organ Failure

  1993cites this paper
• Increased expression of CD11b and functional changes in eosinophils after migration across endothelial cell monolayers.

  1993cites this paper
• DELAYED CARDIAC ALLOGRAFT REJECTION DUE TO COMBINED CYCLOSPORINE AND ANTIOXIDANT THERAPY

  1993cites this paper
• Hepatic Responses to Bacterial Endotoxin (LPS)

  1993cites this paper
• Platelet activating factor stimulates and primes the liver, Kupffer cells and neutrophils to release superoxide anion.

  1992cites this paper
• Protein kinase C activation in murine endothelioma cell lines containing middle T antigen stimulated by platelet-activating factor.

  1992cites this paper
• Human endothelial cells are target for platelet-activating factor. II. Platelet-activating factor induces platelet-activating factor synthesis in human umbilical vein endothelial cells.

  1992cites this paper
• Role of platelet-activating factor in the development of endothelial dysfunction in hemorrhagic hypotension and retransfusion.

  1992cites this paper
• Involvement of platelet‐activating factor and tumour necrosis factor in the pathogenesis of joint inflammation in rabbits

  1992cites this paper
• Differential effects of WEB 2086 and SRI 63-441 on TNF-alpha-induced alterations in cardiopulmonary function.

  1992cites this paper
• Antagonism of platelet-activating factor-induced increase in cytosolic free calcium concentration in human endothelial cells.

  1992cites this paper
• Genetic hypertension and increased susceptibility to cerebral ischemia.

  1992cites this paper
• Lethal and non-lethal course of endotoxic shock is determined by interactions between tumor necrosis factor, platelet activating factor and eicosanoids.

  1992cites this paper
• Effects of esculentoside A on turnour necrosis factor production by mice peritoneal macrophages

  1992cites this paper